Colorado Capital Group is categorized under Pathological Laboratories in Arvada, CO .
Colorado Capital Group was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 5222920 by the NAICS.
If you are seeking more information, feel free to contact Andy Bartoletti, Owner at the company’s single location by writing to 6850 West 52nd Avenue # 105, Arvada, Colorado CO 80002 or by phoning (303) 940-3456. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Colorado Capital Group |
| Contact Person: | Andy Bartoletti, Owner |
| Address: | 6850 West 52nd Avenue # 105, Arvada, Colorado 80002 |
| Phone Number: | (303) 940-3456 |
| Website Address: | ameripath.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 5222920 |
| Share This Business: |
Colorado Capital Group was started in 0 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 5222920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Andy Bartoletti, Owner for inquiries that concern Colorado Capital Group by calling the company number (303) 940-3456, as your correspondence is most welcome. Additionally, the physical location of the single location of Colorado Capital Group can be found at the coordinates 39.791067,-105.07889 as well as the street address 6850 West 52nd Avenue # 105 in Arvada, Colorado 80002.
For its online presence, you may visit Colorado Capital Group’s website at ameripath.com and engage with its social media outlets through on Twitter and on Facebook.